|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06978 IMMUNOTECH-B
Nominal 
2.880 +0.110 (+3.971%) | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | (125,742) | (163,629) | (180,922) | (254,653) | (263,665) |
| Net Cash from / (used in) Investing Activities | 141,103 | (116,597) | 23,381 | (328,206) | (204,067) |
| Net Cash from / (used in) Financing Activities | (20,588) | 273,922 | (36,060) | (10,999) | 1,054,688 |
| Increase / (Decrease) in Cash & Cash Equivalents | (5,227) | (6,304) | (193,601) | (593,858) | 586,956 |
| Cash & Cash Equivalents at beginning of period | 52,161 | 58,448 | 251,401 | 845,386 | 282,247 |
| Effect of Foreign Exchange Rate Changes | 23 | 17 | 648 | (127) | (23,817) |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 46,957 | 52,161 | 58,448 | 251,401 | 845,386 |
| Remarks: | Real time quote last updated: 19/12/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -129,103 |
| %Change | 39.548% |
| EPS / (LPS) | RMB -0.230 |
| NBV Per Share (¥) | RMB -0.254 |